Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Haematology. Supplementum|August 7, 2001
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patientsE Aurlien, H Holte, S Kvaløy, et al.
Thrombosis Research|June 15, 1992
Recurrent venous thrombosis during warfarin treatment related to acquired protein S deficiencyO R Odegaard, A K Lindahl, K Try, et al.
Bone Marrow Transplantation|January 10, 2002
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cellsA K Blystad, H Holte, S Kvaløy, et al.
Virchows Archiv : an International Journal of Pathology|August 4, 1999
Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markersB Davidson, B Risberg, G Kristensen, et al.
Bone Marrow Transplantation|October 12, 1999
Persistent changes in the immune system 4-10 years after ABMTT Nordøy, A Kolstad, P Endresen, et al.
Cancer Research|February 1, 1987
Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodiesG Kvalheim, O Fodstad, A Pihl, et al.
Cancer Research|February 1, 1984
Phase I study of the plant protein ricinO Fodstad, G Kvalheim, A Godal, et al.
Scandinavian Journal of Immunology|November 25, 2003
A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccinesL J Mu, G Gaudernack, S Saebøe-Larssen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1995
Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approachA H Deggerdal, F Pettersen, G Kvalheim, et al.
British Journal of Haematology|May 19, 2004
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapyA K Blystad, J Delabie, S Kvaløy, et al.
Pageof 7